InFocus Therapeutics

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.infocustx.com/

Last Round

Accelerator

Sep 2, 2025

Company Overview

InFocus Therapeutics is a biotechnology company that develops an AI-powered drug discovery platform to identify and optimize RNA-targeting small molecule therapeutics for oncology and neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

RNA-targeted therapeuticssmall-molecule drug discoverygenerative AI drug discoveryAI-powered biotechRNA splice modulatorsAI drug discoveryin silico drug designcomputational chemistrylead optimizationdrug discovery platformAI-first biotechbiotech startuponcology drug discoveryneuroscience drug discoveryAI-driven R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InFocus Therapeutics Comps

Public and private peers based on sector, stage, and business model.

InFocus Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

InFocus Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Sep 2, 2025
Angel	Jul 2, 2025
Accelerator	Jun 5, 2025
Grant	Jul 23, 2024
Accelerator	Apr 10, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Dirk Tomandl

Co-Founder, CTO

Founding Team

Emily Fang

President and CEO

Executive Team

Johnny Yu

Chief Financial Officer

Executive Team

InFocus Therapeutics Investors

Notable investors and investment history

InFocus Therapeutics investors
Investor	Rounds
Berkeley SkyDeck	Accelerator
Taiwan Tech Arena	Accelerator
Mosaic Venture Lab	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 21, 2025
Grew 100% QoQ from 5 to 10 employees.

View all signals

InFocus Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

InFocus Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InFocus Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range10

Year Founded2023

Last FundingSep 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.